Xiaona Jin

663 total citations
34 papers, 561 citations indexed

About

Xiaona Jin is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaona Jin has authored 34 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Radiology, Nuclear Medicine and Imaging, 14 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaona Jin's work include Radiopharmaceutical Chemistry and Applications (14 papers), Cell Adhesion Molecules Research (9 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Xiaona Jin is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (14 papers), Cell Adhesion Molecules Research (9 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Xiaona Jin collaborates with scholars based in China, United States and United Kingdom. Xiaona Jin's co-authors include Bing Jia, Zhaofei Liu, Fan Wang, Zhaohui Zhu, Huiyun Zhao, Jiyun Shi, Fang Li, Fang Li, Chengyan Dong and Shuang Liu and has published in prestigious journals such as PLoS ONE, Radiology and Bioconjugate Chemistry.

In The Last Decade

Xiaona Jin

32 papers receiving 557 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaona Jin China 14 274 190 139 132 115 34 561
Shundong Ji China 13 149 0.5× 122 0.6× 227 1.6× 77 0.6× 64 0.6× 35 500
Monica Santimaria Italy 8 259 0.9× 141 0.7× 160 1.2× 80 0.6× 44 0.4× 11 538
Hildo J.K. Ananias Netherlands 14 271 1.0× 318 1.7× 147 1.1× 30 0.2× 242 2.1× 16 671
Sally‐Ann Ricketts United Kingdom 9 220 0.8× 83 0.4× 160 1.2× 47 0.4× 93 0.8× 18 511
Weibing Miao China 16 291 1.1× 480 2.5× 137 1.0× 79 0.6× 103 0.9× 64 799
Dan Georgess United States 11 146 0.5× 260 1.4× 427 3.1× 92 0.7× 45 0.4× 16 1.0k
Katherine A. Rybinski United States 9 83 0.3× 192 1.0× 190 1.4× 58 0.4× 58 0.5× 23 464
Haili Su China 11 271 1.0× 155 0.8× 335 2.4× 126 1.0× 77 0.7× 19 909
Christoph M. Griessinger Germany 12 194 0.7× 196 1.0× 103 0.7× 63 0.5× 62 0.5× 18 514
Markus Niemeyer Germany 14 375 1.4× 208 1.1× 223 1.6× 222 1.7× 102 0.9× 18 948

Countries citing papers authored by Xiaona Jin

Since Specialization
Citations

This map shows the geographic impact of Xiaona Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaona Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaona Jin more than expected).

Fields of papers citing papers by Xiaona Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaona Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaona Jin. The network helps show where Xiaona Jin may publish in the future.

Co-authorship network of co-authors of Xiaona Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaona Jin. A scholar is included among the top collaborators of Xiaona Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaona Jin. Xiaona Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xing, Haiqun, et al.. (2023). Direct attenuation correction for 99mTc-3PRGD2 chest SPECT lung cancer images using deep learning. Frontiers in Oncology. 13. 1165664–1165664. 3 indexed citations
2.
3.
Jin, Xiaona, Fang Li, Libo Chen, & Hongli Jing. (2021). Breast Carcinoma Shown on 99mTc-HYNIC-TOC Study Performed to Evaluate Tumor-Induced Osteomalacia. Clinical Nuclear Medicine. 47(2). 197–199. 1 indexed citations
4.
Jin, Xiaona, Chengyan Dong, Ximin Shi, et al.. (2021). Scintigraphic Imaging of Neovascularization With 99mTc-3PRGD2 for Evaluating Early Response to Endostar Involved Therapies on Pancreatic Cancer Xenografts In Vivo. Frontiers in Oncology. 11. 792431–792431. 47 indexed citations
5.
Jin, Xiaona, Li Huo, Tong Wang, Yü Liu, & Fang Li. (2019). Hepatosplenic Tuberculosis on Pretherapy and Posttherapy FDG PET/CT. Clinical Nuclear Medicine. 45(2). 174–176. 3 indexed citations
6.
7.
Wang, Ling, Xiaona Jin, & Fang Li. (2018). Long-lasting Intense Bone Tracer Activity at the Sites of Collagen Injection. Clinical Nuclear Medicine. 43(5). 372–374. 2 indexed citations
8.
Jin, Xiaona, Hongli Jing, Yu Liu, & Fang Li. (2016). Familial Gigantiform Cementoma on 99mTc MDP Bone Scintigraphy. Clinical Nuclear Medicine. 41(11). 896–898. 1 indexed citations
9.
Qiao, Zhen, Jingjing Zhang, Xiaona Jin, et al.. (2015). 99mTc-HYNIC-TOC Imaging in the Evaluation of Pancreatic Masses Which are Potential Neuroendocrine Tumors. Clinical Nuclear Medicine. 40(5). 397–400. 10 indexed citations
10.
Miao, Weibing, Shan Zheng, Feng Wang, et al.. (2014). Comparison of 99mTc-3PRGD2 Integrin Receptor Imaging with 99mTc-MDP Bone Scan in Diagnosis of Bone Metastasis in Patients with Lung Cancer: A Multicenter Study. PLoS ONE. 9(10). e111221–e111221. 19 indexed citations
11.
Shi, Jiyun, Di Fan, Chengyan Dong, et al.. (2014). Anti-tumor Effect of Integrin Targeted 177Lu-3PRGD2 and Combined Therapy with Endostar. Theranostics. 4(3). 256–266. 30 indexed citations
12.
Jin, Xiaona, Yunxiao Meng, Zhaohui Zhu, Hongli Jing, & Fang Li. (2013). Elevated 99mTc 3PRGD2 Activity in Benign Metastasizing Leiomyoma. Clinical Nuclear Medicine. 38(2). 117–119. 12 indexed citations
13.
Zhu, Zhaohui, et al.. (2013). Combined 18F-FDG PET/CT and 99mTc 3PRGD2 SPECT/CT Imaging in a Case of Pituitary Metastases. Clinical Nuclear Medicine. 38(7). 550–552. 7 indexed citations
14.
Cheng, Wuying, et al.. (2012). Intense FDG Activity in the Brown Adipose Tissue in Omental and Mesenteric Regions in a Patient With Malignant Pheochromocytoma. Clinical Nuclear Medicine. 37(5). 514–515. 24 indexed citations
15.
Cui, Liyang, Zhaofei Liu, Xiaona Jin, et al.. (2012). Evaluation of 188Re-MAG2-RGD-bombesin for potential prostate cancer therapy. Nuclear Medicine and Biology. 40(2). 182–189. 17 indexed citations
16.
Zhao, Dan, Xiaona Jin, Fang Li, Jun Liang, & Yansong Lin. (2012). Integrin αvβ3 Imaging of Radioactive Iodine–Refractory Thyroid Cancer Using 99mTc-3PRGD2. Journal of Nuclear Medicine. 53(12). 1872–1877. 57 indexed citations
17.
Shi, Ximin, Hongli Jing, Hongming Zhuang, et al.. (2011). Diffuse Hepatic and Splenic Uptake of Tc-99m Methylene Diphosphonate on Bone Scintigraphy After Intravenous Administration of Gadolinium-Containing MRI Contrast. Clinical Nuclear Medicine. 36(3). 178–182. 17 indexed citations
18.
Liu, Zhaofei, Yan Liu, Bing Jia, et al.. (2010). Epidermal Growth Factor Receptor–Targeted Radioimmunotherapy of Human Head and Neck Cancer Xenografts Using 90Y-Labeled Fully Human Antibody Panitumumab. Molecular Cancer Therapeutics. 9(8). 2297–2308. 26 indexed citations
19.
Shi, Jiyun, Yan Liu, Jinming Huang, et al.. (2010). Comparison of in vitro and in vivo characteristics of 99 Tc m -labeled cyclic RGD dimers with PEG 4 /2PEG 4 linkers. 32(5). 287–292. 1 indexed citations
20.
Jia, Bing, Zhaofei Liu, Zhaohui Zhu, et al.. (2010). Blood Clearance Kinetics, Biodistribution, and Radiation Dosimetry of a Kit-Formulated Integrin αvβ3-Selective Radiotracer 99mTc-3PRGD2 in Non-Human Primates. Molecular Imaging and Biology. 13(4). 730–736. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shundong Ji Breakdown of academic impact, for papers by Monica Santimaria Breakdown of academic impact, for papers by Hildo J.K. Ananias Breakdown of academic impact, for papers by Sally‐Ann Ricketts Breakdown of academic impact, for papers by Weibing Miao Breakdown of academic impact, for papers by Dan Georgess Breakdown of academic impact, for papers by Katherine A. Rybinski Breakdown of academic impact, for papers by Haili Su Breakdown of academic impact, for papers by Christoph M. Griessinger Breakdown of academic impact, for papers by Markus Niemeyer
Rankless by CCL
2026